NO20044927L - Fremgangsmate for syntese av beta-L-5-fluor-2`,3`-dideoksy-2`,3`-dihydrocutidin (beta-L-FD4C) - Google Patents

Fremgangsmate for syntese av beta-L-5-fluor-2`,3`-dideoksy-2`,3`-dihydrocutidin (beta-L-FD4C)

Info

Publication number
NO20044927L
NO20044927L NO20044927A NO20044927A NO20044927L NO 20044927 L NO20044927 L NO 20044927L NO 20044927 A NO20044927 A NO 20044927A NO 20044927 A NO20044927 A NO 20044927A NO 20044927 L NO20044927 L NO 20044927L
Authority
NO
Norway
Prior art keywords
beta
fd4c
dideoxy
fluoro
dihydrocutidine
Prior art date
Application number
NO20044927A
Other languages
English (en)
Inventor
Bo Kowalczyk
Lei Zhao
Ralph M Schure
Lisa Dunkle
Original Assignee
Achillion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achillion Pharmaceuticals Inc filed Critical Achillion Pharmaceuticals Inc
Publication of NO20044927L publication Critical patent/NO20044927L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Det er tilveiebrakt en fremgangsmåte for å syntetisere P-L-5-fluor-2',3'-dideoksy-2',3'didehydrocytidin ((-L-FD4C). Fremgangsmåten muliggjør storskalafremstilling av P-LFD4C på en effektiv, kostnadseffektiv og miljøvennlig måte.
NO20044927A 2002-04-12 2004-11-11 Fremgangsmate for syntese av beta-L-5-fluor-2`,3`-dideoksy-2`,3`-dihydrocutidin (beta-L-FD4C) NO20044927L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37200602P 2002-04-12 2002-04-12
PCT/US2003/011445 WO2003087119A1 (en) 2002-04-12 2003-04-11 METHOD FOR SYNTHESIZING β-L-FLUORO-2´,3´DIDEHYDROCYTIDINE (β-L-FD4C)

Publications (1)

Publication Number Publication Date
NO20044927L true NO20044927L (no) 2005-01-10

Family

ID=29250776

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044927A NO20044927L (no) 2002-04-12 2004-11-11 Fremgangsmate for syntese av beta-L-5-fluor-2`,3`-dideoksy-2`,3`-dihydrocutidin (beta-L-FD4C)

Country Status (14)

Country Link
US (1) US6897302B2 (no)
EP (1) EP1495040A4 (no)
JP (1) JP2005527589A (no)
KR (1) KR20050005442A (no)
CN (1) CN1329407C (no)
AU (1) AU2003234737B2 (no)
BR (1) BR0309111A (no)
CA (1) CA2481572A1 (no)
MX (1) MXPA04009986A (no)
NO (1) NO20044927L (no)
PL (1) PL371913A1 (no)
RU (1) RU2310661C2 (no)
UA (1) UA77291C2 (no)
WO (1) WO2003087119A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008279424B2 (en) * 2007-07-26 2013-06-13 Lexicon Pharmaceuticals, Inc. Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
PT2562166E (pt) * 2008-01-22 2015-10-28 Dow Agrosciences Llc Derivados de 5-fluoro-pirimidina como fungicidas
SG11201407336PA (en) 2012-05-25 2015-03-30 Janssen Sciences Ireland Uc Uracyl spirooxetane nucleosides
US20260008802A1 (en) * 2022-11-15 2026-01-08 Ecole Polytechnique Federale De Lausanne (Epfl) Method for preparing an at least partially acetal-protected sugar

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
NZ241625A (en) 1991-02-22 1996-03-26 Univ Emory 1,3-oxathiolane derivatives, anti-viral compositions containing such and method of resolving racemic mixture of enantiomers
RU2085557C1 (ru) * 1991-09-30 1997-07-27 Санкио Компани Лимитед Производные нуклеозидов пиримидина или их фармацевтически приемлемые соли и способ их получения
TW374087B (en) 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5627160A (en) 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
US5703058A (en) 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
US6005097A (en) 1996-06-14 1999-12-21 Vion Pharmaceuticals, Inc. Processes for high-yield diastereoselective synthesis of dideoxynucleosides
US6280940B1 (en) 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
CA2341540A1 (en) 1998-08-25 2000-03-02 Yale University Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
ES2263687T3 (es) 2000-11-20 2006-12-16 Bristol-Myers Squibb Company Inhibidores tripeptidicos de la hepatitis c.
WO2002057425A2 (en) 2001-01-22 2002-07-25 Merck & Co., Inc. Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
US6689559B2 (en) 2001-11-29 2004-02-10 The Research Foundation Of The State University Of New York Efficient hepatitis C virus replicon and its use in identifying antiviral compounds

Also Published As

Publication number Publication date
PL371913A1 (en) 2005-07-11
AU2003234737B2 (en) 2009-08-27
US20040147479A1 (en) 2004-07-29
KR20050005442A (ko) 2005-01-13
EP1495040A1 (en) 2005-01-12
CN1329407C (zh) 2007-08-01
US6897302B2 (en) 2005-05-24
UA77291C2 (en) 2006-11-15
CA2481572A1 (en) 2003-10-23
BR0309111A (pt) 2005-02-01
JP2005527589A (ja) 2005-09-15
AU2003234737A1 (en) 2003-10-27
WO2003087119A1 (en) 2003-10-23
CN1653078A (zh) 2005-08-10
EP1495040A4 (en) 2006-01-25
RU2310661C2 (ru) 2007-11-20
RU2004133062A (ru) 2005-06-10
MXPA04009986A (es) 2005-08-16

Similar Documents

Publication Publication Date Title
NO20050650L (no) Fremgangsmate for selektiv fremstilling av aryl-5-tio- -D-aldoheksopyranosider
NO982850L (no) Ny syntese
YU82403A (sh) Jedinjenja spiropirazola
AU6350699A (en) Chemical compounds
YU55003A (sh) Poboljšani postupak za sintezu karbapenema
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
AU2003255483A1 (en) Process for the conversion of polysulfanes
AU2003256609A1 (en) Novel synthesis of irbesartan
WO2002044194A1 (en) L-nucleic acid derivatives and processes for the synthesis thereof
DE60232289D1 (de) Photopolymerisierbare Verbindungen
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
PL367774A1 (en) Synthesis and intermediates
NO20044927L (no) Fremgangsmate for syntese av beta-L-5-fluor-2`,3`-dideoksy-2`,3`-dihydrocutidin (beta-L-FD4C)
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
WO2005005461A3 (fr) Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
AU5209699A (en) Synthesis of compounds useful in the manufacture of ketorolac
MXPA04004937A (es) Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
PT1086114E (pt) Sintese da morfina-6-glucuronido
HK1052350A1 (zh) 一種合成嗎啉基苯類化合物的新方法
WO2000003681A3 (en) Process for the synthesis of benzopyran derivatives
CA2386492A1 (en) Process for the production of n,n-carbonyl diimidazole
MXPA04003085A (es) Proceso estereoespecifico para sintesis de derivados de 2-il cromano.
MXPA04004526A (es) N-metil-homocisteinas, su uso y metodo para su produccion.
AU2003261853A1 (en) Process for preparing azo compound
MY136989A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application